The Conversation (0)
Ayurcann (CSE:AYUR) has launched its campaign on the Investing News Network
Ayurcann (CSE:AYUR) provides scalable custom processes and pharma-grade products to the medical cannabis industry in Canada. Ayurcann is focused on becoming the partner of choice for leading Canadian cannabis brands by delivering best-in-class, proprietary services, including ethanol extraction, formulation, product development and custom manufacturing.
The company offers a two-tier business model of services and production. The manufacturing vertical offers three production divisions specializing in expert cannabis-based extraction and refinement, high-quality bulk oil sales and white label manufacturing. Ayurcann currently extracting approximately 1,500 kilograms a week of product and has the capacity to process up to 200,000 kilograms of dry cannabis annually.
Ayurcann’s Company Highlights
- Ayurcann is a premier post-harvest cannabis solutions company focused on providing and manufacturing unique development processes and high-quality products for patient and adult use in Canada.
- The company aims to be a market leader and supportive partner within the cannabis extraction business. It has created turn-key-post harvest outsourcing for licensed cannabis producers, using a strategic end-to-end model.
- The company’s Ayurcann Solutions offers premium services across various cannabis production verticals. This portfolio includes expert cannabis-based extraction and refinement, high-quality bulk oil sales and white label manufacturing.
- Ayurcann also operates the Ayurcann Marketplace, specializing in safe and well-engineered medicinal cannabis concentrate products for personalized and patient care.
